Literature DB >> 22631061

Partial portal arterialization for hepatic arterial thrombosis after living-donor liver transplant.

Hironori Hayashi1, Hiroyuki Takamura, Takashi Tani, Isamu Makino, Hisatoshi Nakagawara, Hidehiro Tajima, Hirohisa Kitagawa, Ichiro Onishi, Koichi Shimizu, Tetsuo Ohta.   

Abstract

OBJECTIVES: The most serious, life-threatening complication after living-donor liver transplant is a hepatic arterial thrombosis. Although possible therapies for acute hepatic arterial thrombosis include revascularization to salvage the graft, or retransplant, these may be difficult to perform owing to technical aspects and donor shortages. Previously, we reported the usefulness of partial portal arterialization in such cases.
MATERIALS AND METHODS: Four cases of partial portal arterialization for hepatic arterial occlusion after living-donor liver transplant were reviewed. The surgical procedure of partial portal arterializations involves making an arteriovenous shunt via a side-to-side anastomosis, using mesenteric vessels approximately 2 mm in diameter.
RESULTS: After partial portal arterialization, hepatic arterial flow was not detected, but graft injury owing to hypoxia gradually improved in all cases. In 1 case, occlusion of the arteriovenous shunt itself and the collateral artery to the graft were identified by angiography 45 days after partial portal arterialization. In another case, massive ascites, pleural effusion, and variceal changes of the mesenteric veins owing to portal hypertension were identified, and surgical closure of the shunt was performed 152 days after partial portal arterialization. In the other 2 cases, there were no definite problems related to partial portal arterialization, but the patients died owing to other complications.
CONCLUSIONS: When hepatic arterial thrombosis occurs after living-donor liver transplant, revascularization should be performed first. However, this sometimes may be difficult, as when the arterial dissection reaches into the graft. Partial portal arterialization is an easy and effective surgical procedure. Therefore, partial portal arterialization appears to be a useful option to gain time until collateral arterial vessels develop or retransplant, even if revascularization cannot be performed.

Entities:  

Mesh:

Year:  2012        PMID: 22631061     DOI: 10.6002/ect.2011.0173

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  5 in total

1.  Gastroepiploic arteriovenous shunt as a salvage treatment for hepatic artery occlusion after living donor liver transplantation.

Authors:  Seong Hoon Kim; Sang Jae Park
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

Review 2.  Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experience.

Authors:  Prashant Bhangui; Chady Salloum; Chetana Lim; Paola Andreani; Arie Ariche; René Adam; Denis Castaing; Tech Kerba; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2013-12-12       Impact factor: 3.647

Review 3.  Management of early hepatic artery occlusion after liver transplantation with failed rescue.

Authors:  Chih-Yang Hsiao; Cheng-Maw Ho; Yao-Ming Wu; Ming-Chih Ho; Rey-Heng Hu; Po-Huang Lee
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  Partial portal vein arterialization during living-donor liver transplantation: a case report.

Authors:  Yasuhiro Maruya; Masaaki Hidaka; Florian Pecquenard; Alzhan Baubekov; Yuki Nunoshita; Shinichiro Ono; Tomohiko Adachi; Mitsuhisa Takatsuki; Katsumi Tanaka; Shinichiro Ito; Kengo Kanetaka; Susumu Eguchi
Journal:  Surg Case Rep       Date:  2020-01-08

5.  Price to pay; Portal vein arterialization for hepatic artery thrombosis after living donor liver transplantation; A case report.

Authors:  Worakitti Lapisatepun; Anon Chotirosniramit; Trichak Sandhu; Kanya Udomsin; Wasana Ko-Iam; Phuriphong Chanthima; Warangkana Lapisatepun; Settapong Boonsri; Suraphong Lorsomradee; Quanhathai Kaewpoowat; Sunhawit Junrungsee
Journal:  Int J Surg Case Rep       Date:  2018-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.